Immune suppression: The most precisely documented harm. Each doubling of serum PFOS in children is associated with a 49% reduction in vaccine antibody response (Grandjean et al., JAMA 2012). The National Toxicology Program classifies PFOS as a "presumed immune hazard in humans."
Cancer: IARC classifies PFOS as "possibly carcinogenic" (Group 2B). The C8 Science Panel found probable links to kidney and testicular cancer. Emerging evidence connects PFOS to thyroid and breast cancer.
Thyroid disruption: Higher serum PFOS is associated with decreased free T4, increased TSH, and elevated thyroid disease risk. Critical concern during pregnancy when fetal brain development depends on maternal thyroid hormones.
Reproductive harm: Crosses the placenta. Associated with reduced birth weight, preeclampsia, reduced sperm quality, lower testosterone, and longer time to pregnancy.
Cholesterol: Dose-dependent relationship with elevated total and LDL cholesterol, the most consistently replicated finding across PFOS studies.
Developmental effects: Children with higher PFOS exposure show increased obesity risk, delayed motor development, and reduced cognitive performance.